Source: ScienceDaily Health

Summary

Researchers have identified mutations in the CD99L2 gene as a new genetic cause of a rare movement disorder, analyzing data from nearly 3,000 patients. This groundbreaking discovery sheds light on the gene’s crucial role in nerve-cell communication, expanding its previously understood functions.

Why It Matters

This finding is significant as it not only enhances our understanding of the genetic factors behind movement disorders but also opens avenues for potential new treatments. By linking CD99L2 to neurological function, researchers can explore targeted therapies that may improve symptoms for affected individuals. Such advancements could transform the lives of patients dealing with coordination and muscle control issues.

Read the full article →